AgeX Therapeutics Inc
F:0X4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AgeX Therapeutics Inc
F:0X4
|
US |
|
Scandinavian Investment Group A/S
F:2D2
|
DK |
Intrinsic Value
The intrinsic value of AgeX Therapeutics Inc (0X4) under the Base Case is 0.3575 EUR per share. Compared with the current market price of 17.4443 EUR, the stock appears Overvalued by 98% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What AgeX Therapeutics Does
AgeX Therapeutics is a biotechnology company focused on regenerative medicine. It works on cell-based therapies and related technologies that are meant to replace, repair, or restore damaged tissue, with an emphasis on conditions tied to aging and chronic disease. Its core idea is to use human stem cell science to build treatments that go beyond managing symptoms and instead aim to address the underlying tissue loss.
- Headquarters
- United States of America US
- Employees
- 5
- IPO date
- Nov 29, 2018
Revenue & Expenses Breakdown
AgeX Therapeutics Inc
Earnings Waterfall
AgeX Therapeutics Inc
The intrinsic value for AgeX Therapeutics Inc (0X4) under the Base Case is 0.3575 EUR.
Compared with the current market price of 17.4443 EUR, the stock appears Overvalued by 98% .